About ATX
Amplia Therapeutics (ATX) develops FAK inhibitors for fibrotic cancers such as pancreatic and ovarian cancer, and for chronic conditions like idiopathic pulmonary fibrosis.
All News for ATX
No news articles found for ATX yet.
ATX
Health Care Sector News